Literature DB >> 19499549

A simple G-computation algorithm to quantify the causal effect of a secondary illness on the progression of a chronic disease.

W M van der Wal1, M Prins, B Lumbreras, R B Geskus.   

Abstract

Progression of a chronic disease can lead to the development of secondary illnesses. An example is the development of active tuberculosis (TB) in HIV-infected individuals. HIV disease progression, as indicated by declining CD4 + T-cell count (CD4), increases both the risk of TB and the risk of AIDS-related mortality. This means that CD4 is a time-dependent confounder for the effect of TB on AIDS-related mortality. Part of the effect of TB on AIDS-related mortality may be indirect by causing a drop in CD4. Estimating the total causal effect of TB on AIDS-related mortality using standard statistical techniques, conditioning on CD4 to adjust for confounding, then gives an underestimate of the true effect. Marginal structural models (MSMs) can be used to obtain an unbiased estimate. We describe an easily implemented algorithm that uses G-computation to fit an MSM, as an alternative to inverse probability weighting (IPW). Our algorithm is simplified by utilizing individual baseline parameters that describe CD4 development. Simulation confirms that the algorithm can produce an unbiased estimate of the effect of a secondary illness, when a marker for primary disease progression is both a confounder and intermediary for the effect of the secondary illness. We used the algorithm to estimate the total causal effect of TB on AIDS-related mortality in HIV-infected individuals, and found a hazard ratio of 3.5 (95 per cent confidence interval 1.2-9.1). Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19499549     DOI: 10.1002/sim.3629

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

1.  Marginal Structural Models: unbiased estimation for longitudinal studies.

Authors:  Erica E M Moodie; D A Stephens
Journal:  Int J Public Health       Date:  2010-10-08       Impact factor: 3.380

2.  Introducing the at-risk average causal effect with application to HealthWise South Africa.

Authors:  Donna L Coffman; Linda L Caldwell; Edward A Smith
Journal:  Prev Sci       Date:  2012-08

3.  The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death.

Authors:  Daniel Westreich; Stephen R Cole; Jessica G Young; Frank Palella; Phyllis C Tien; Lawrence Kingsley; Stephen J Gange; Miguel A Hernán
Journal:  Stat Med       Date:  2012-04-11       Impact factor: 2.373

4.  Estimation of Generalized Impact Fraction and Population Attributable Fraction of Hypertension Based on JNC-IV and 2017 ACC/AHA Guidelines for Cardiovascular Diseases Using Parametric G-Formula: Tehran Lipid and Glucose Study (TLGS).

Authors:  Mohammad Saatchi; Mohammad Ali Mansournia; Davood Khalili; Rajabali Daroudi; Kamran Yazdani
Journal:  Risk Manag Healthc Policy       Date:  2020-08-05

5.  Assessing mediation using marginal structural models in the presence of confounding and moderation.

Authors:  Donna L Coffman; Wei Zhong
Journal:  Psychol Methods       Date:  2012-08-20

6.  Estimating parsimonious models of longitudinal causal effects using regressions on propensity scores.

Authors:  Russell T Shinohara; Anand K Narayan; Kelvin Hong; Hyun S Kim; Josef Coresh; Michael B Streiff; Constantine E Frangakis
Journal:  Stat Med       Date:  2013-03-27       Impact factor: 2.373

7.  Non-ignorable loss to follow-up: correcting mortality estimates based on additional outcome ascertainment.

Authors:  M Schomaker; T Gsponer; J Estill; M Fox; A Boulle
Journal:  Stat Med       Date:  2013-07-22       Impact factor: 2.373

8.  A review of time scale fundamentals in the g-formula and insidious selection bias.

Authors:  Alexander P Keil; Jessie K Edwards
Journal:  Curr Epidemiol Rep       Date:  2018-06-15

9.  Association between Circulating Protein C Levels and Incident Dementia: The Atherosclerosis Risk in Communities Study.

Authors:  Adrienne Tin; Keenan A Walker; Jan Bressler; B Gwen Windham; Michael Griswold; Kevin Sullivan; Aozhou Wu; Rebecca Gottesman; Myriam Fornage; Josef Coresh; A Richey Sharrett; Aaron R Folsom; Thomas H Mosley
Journal:  Neuroepidemiology       Date:  2021-06-02       Impact factor: 5.393

10.  When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.

Authors:  Michael Schomaker; Matthias Egger; James Ndirangu; Sam Phiri; Harry Moultrie; Karl Technau; Vivian Cox; Janet Giddy; Cleophas Chimbetete; Robin Wood; Thomas Gsponer; Carolyn Bolton Moore; Helena Rabie; Brian Eley; Lulu Muhe; Martina Penazzato; Shaffiq Essajee; Olivia Keiser; Mary-Ann Davies
Journal:  PLoS Med       Date:  2013-11-19       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.